Relay Therapeutics, Inc. (RLAY)

NASDAQ: RLAY · Real-Time Price · USD

17.28

-1.07 (-5.83%)

At close: Nov 2, 2026, 4:00 PM EST

17.30

+0.02 (0.12%)

After-hours: Nov 2, 2026, 7:30 PM EST

Relay Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	10.35	15.36	10.01	25.55	1.38	3.03
Revenue Growth	23.88%	53.44%	-60.83%	1749.82%	-54.41%	-96.34%
Cost of Revenue	268.85	257.21	315.44	326.39	243.01	169.39
Gross Profit	-258.5	-241.85	-305.43	-300.84	-241.62	-166.36
Selling, General & Admin	51.94	58.59	80.24	78.58	69.33	59.75
Operating Expenses	51.94	58.59	80.24	78.58	69.33	59.75
Operating Income	-310.44	-300.44	-385.67	-379.42	-310.95	-226.11
Interest & Investment Income	24.58	27.04	34.75	31.05	8.79	0.83
Other Non Operating Income (Expenses)	-0.19	-0.78	0.01	-0.02	-0.02	-0
EBT Excluding Unusual Items	-286.04	-274.18	-350.91	-348.4	-302.19	-225.28
Merger & Restructuring Charges	-	-	-	-	-	-0.9
Gain (Loss) on Sale of Investments	-	-	-	-	-	-11.86
Asset Writedown	-	-2.3	-	-	-	-
Other Unusual Items	-	-	13.21	6.42	11.68	-2.84
Pretax Income	-286.04	-276.48	-337.71	-341.97	-290.51	-363.87
Net Income	-286.04	-276.48	-337.71	-341.97	-290.51	-363.87
Net Income to Common	-286.04	-276.48	-337.71	-341.97	-290.51	-363.87
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	182	172	143	123	112	95
Shares Outstanding (Diluted)	182	172	143	123	112	95
Shares Change	12.39%	20.10%	16.55%	9.21%	17.97%	123.22%
EPS (Basic)	-1.57	-1.61	-2.36	-2.79	-2.59	-3.82
EPS (Diluted)	-1.57	-1.61	-2.36	-2.79	-2.59	-3.82
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-212.21	-235.87	-251.13	-304.44	-238.55	-77.88
Free Cash Flow Per Share	-1.17	-1.38	-1.76	-2.48	-2.13	-0.82
Operating Margin	-2999.37%	-1956.61%	-3854.04%	-1485.25%	-22516.44%	-7464.74%
Profit Margin	-2763.64%	-1800.58%	-3374.72%	-1338.66%	-21036.13%	-12012.94%
Free Cash Flow Margin	-2050.29%	-1536.08%	-2509.49%	-1191.74%	-17273.86%	-2571.05%
EBITDA	-308.22	-296.88	-380.21	-374.15	-306.82	-222.18
D&A For EBITDA	2.21	3.56	5.46	5.27	4.13	3.93
EBIT	-310.44	-300.44	-385.67	-379.42	-310.95	-226.11
Revenue as Reported	10.35	15.36	10.01	25.55	1.38	3.03

SEC Filings: 10-K · 10-Q